African swine fever virus

Polydex Pharmaceuticals Issues Year End Financial Results

Retrieved on: 
Lundi, mai 2, 2022

The company is receiving some orders from Europe but is encountering logistical problems with shipping due to COVID and the situation in Ukraine.

Key Points: 
  • The company is receiving some orders from Europe but is encountering logistical problems with shipping due to COVID and the situation in Ukraine.
  • While the pandemic continues to be of concern, we continue to receive orders from Europe, noted George Usher, President and CEO.
  • The company continues full disclosure of its financial and operational results, which can be accessed by visiting the company website at www.Polydex.com .
  • Other risk factors discussed in the Companys financial reports may also affect the actual results achieved by the Company.

US Biologic® to Present at World Vaccine Congress on April 20

Retrieved on: 
Lundi, avril 18, 2022

MEMPHIS, Tenn., April 18, 2022 /PRNewswire/ -- US Biologic today announced that Dr. Jolieke G. van Oosterwijk, Chief Scientific Officer, will present at the World Vaccine Congress Washington 2022 in Washington, D.C. on Wednesday, April 20, 2022, at 3:25 p.m.

Key Points: 
  • MEMPHIS, Tenn., April 18, 2022 /PRNewswire/ -- US Biologic today announced that Dr. Jolieke G. van Oosterwijk, Chief Scientific Officer, will present at the World Vaccine Congress Washington 2022 in Washington, D.C. on Wednesday, April 20, 2022, at 3:25 p.m.
  • Surveillance is not the last step to prevent pandemics that can cost millions of lives and trillions in economic damage.
  • Dr. van Oosterwijk will speak on "Using zoonotic disease surveillance to guide oral vaccine design" and will present the methods US Biologic uses to effectively prevent pandemic-level diseases at first surveillance.
  • In the presentation, Dr. van Oosterwijk will connect effective surveillance, rapid vaccine design, manufacturing, and application, as well interactions between complementary animal and human vaccination campaigns.

ATCC Announces Two Projects from the U.S. Department of Agriculture’s Chief Scientific In-House Research Agency, the Agricultural Research Service

Retrieved on: 
Mardi, avril 12, 2022

For the second project, ATCC will create genetically modified cell lines capable of growing and producing African Swine Fever Virus (ASFV) vaccines.

Key Points: 
  • For the second project, ATCC will create genetically modified cell lines capable of growing and producing African Swine Fever Virus (ASFV) vaccines.
  • Through these two projects, we will continue to support the USDA and strive to help the ARS achieve its mission of delivering scientific solutions to national and global agricultural challenges, said Raymond H. Cypess, D.V.M., Ph.D., chairman and CEO of ATCC.
  • African Swine Fever is a devastating disease of domestic and feral swine and causes a significant economic impact on the agricultural industry.
  • ATCC is a 501(c)3 nonprofit organization with headquarters in Manassas, Virginia, and a research and technology center of excellence in Gaithersburg, Maryland.

The Animal Protection Party of Canada says CFIA Abdicates Responsibility Over African Swine Fever to Industry

Retrieved on: 
Lundi, mars 28, 2022

TORONTO, March 28, 2022 (GLOBE NEWSWIRE) -- The Animal Protection Party of Canada is raising the alarm over the federal governments proposed National Compartmentalization Program (NCP) for African Swine Fever (ASF) to prevent and manage the disease in Canada.

Key Points: 
  • TORONTO, March 28, 2022 (GLOBE NEWSWIRE) -- The Animal Protection Party of Canada is raising the alarm over the federal governments proposed National Compartmentalization Program (NCP) for African Swine Fever (ASF) to prevent and manage the disease in Canada.
  • The party is calling on the Canadian Food Inspection Agency (CFIA) to fulfill its mandate to safeguard animal health.
  • Although ASF has not yet been found in Canada or the U.S., most believe it is just a matter of time.
  • The industry responsible for these conditions should not be the one to police them, he added.

Zoetis Named One of Most Innovative Companies in 2022 by Fast Company

Retrieved on: 
Mercredi, mars 9, 2022

Zoetis has been named to Fast Companys list of Most Innovative Companies for 2022 , ranking eighth in the corporate social responsibility category.

Key Points: 
  • Zoetis has been named to Fast Companys list of Most Innovative Companies for 2022 , ranking eighth in the corporate social responsibility category.
  • In addition to the World's 50 Most Innovative Companies, 528 organizations are recognized across 52 categories.
  • In other recognitions of its progress on sustainability, Zoetis was named one of Newsweeks Most Responsible Companies for 2022 and was included in Investors Business Dailys 100 Best ESG Companies .
  • All trademarks are the property of Zoetis Services LLC or a related company or a licensor unless otherwise noted.

Veterinary Diagnostics: COVID-19 Pandemic Can't Slow Momentum of $3.5 Billion Market

Retrieved on: 
Mercredi, mars 9, 2022

Ultimately, the market is expected to experience a compound annual growth rate (CAGR) of 7.7% from 2021-2026.

Key Points: 
  • Ultimately, the market is expected to experience a compound annual growth rate (CAGR) of 7.7% from 2021-2026.
  • Companies enter the veterinary diagnostics market through acquisitions, product development, and licensing or OEM agreements.
  • Low barriers to market entry and a lack of insurmountable competition makes superior rates of growth in certain segments of the veterinary diagnostics market realizable for a broad range of companies.
  • For more information or to purchase The World Market for Veterinary Diagnostics, 5th Edition visit: https://kaloramainformation.com/product/the-world-market-for-veterinary-... .

Genus plc Reports Interim Results for the Six Months Ended 31 December 2021

Retrieved on: 
Jeudi, février 24, 2022

The board is monitoring closely the potential risks to Genus and its employees of the geopolitical situation in Russia and the Ukraine.

Key Points: 
  • The board is monitoring closely the potential risks to Genus and its employees of the geopolitical situation in Russia and the Ukraine.
  • The Board remains confident in the Group's strategy, the many opportunities for Genus and medium-term growth expectations remain unchanged.
  • Genus advances animal breeding and genetic improvement by applying biotechnology and sells added value products for livestock farming and food producers.
  • Constant currency percentage movements are calculated by restating the results for the six months ended 31 December 2021 at the average exchange rates applied to adjusted operating profit for the year ended 30 June 2021.

Animal Biotechnology Market Size to grow by USD 3.26 billion | 51% of the market's growth to originate from North America| 17,000+ Technavio Reports

Retrieved on: 
Lundi, février 21, 2022

North America held the largest animal biotechnology market share in 2021.

Key Points: 
  • North America held the largest animal biotechnology market share in 2021.
  • Furthermore, countries such as Germany, China, Canada, and UK are expected to emerge as prominent markets for animal biotechnology market during the forecast period.
  • In addition, the increasing prevalence of animal diseases will also influence the market's growth positively during the forecast period.
  • Download free sample for highlights on market Drivers & Challenges affecting the animal biotechnology market.

CoBank Quarterly: US Monetary Policy Poised to Replace COVID as Economic Wild Card

Retrieved on: 
Jeudi, janvier 13, 2022

Economic risks from new, high-impact coronavirus variants will remain throughout 2022, said Dan Kowalski , vice president of CoBanks Knowledge Exchange division.

Key Points: 
  • Economic risks from new, high-impact coronavirus variants will remain throughout 2022, said Dan Kowalski , vice president of CoBanks Knowledge Exchange division.
  • As the labor market inches closer to full employment, any last arguments for the Federal Reserve to maintain its highly accommodative monetary policy are losing their merit.
  • With the market now anticipating a sea change in monetary policy, the tightening of financial conditions has begun.
  • Headquartered outside Denver, Colorado, CoBank serves customers from regional banking centers across the U.S. and maintains an international representative office in Singapore.

AGRI Developments Expands into the Protein Market with new Pork Venture

Retrieved on: 
Jeudi, janvier 13, 2022

MANILA, Philippines, Jan. 13, 2022 /PRNewswire/ --AGRI Developments today announced it has entered the global pork protein market with its latest venture in the Philippines.

Key Points: 
  • MANILA, Philippines, Jan. 13, 2022 /PRNewswire/ --AGRI Developments today announced it has entered the global pork protein market with its latest venture in the Philippines.
  • AGRI Developments will be expanding the operators existing production capacity immediately in response to the pork supply crisis across the country.
  • African Swine Fever has devastated the Philippines and has highlighted the importance of food security and sustainable means of production," stated Mr. van Egeraat, CEO of AGRI Developments.
  • AGRI Developments in support of the world's needs always aims to do more with less.